Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
Assertio Therapeutics (ASRT) Stock Price & Analysis
991 Followers
ASRT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.77 - $8.01
Previous Close$0.87
Volume506.54K
Average Volume (3M)932.18K
Market Cap
$82.48M
Enterprise Value$47.55M
Total Cash (Recent Filing)$73.44M
Total Debt (Recent Filing)$38.51M
Price to Earnings (P/E)-0.2
Beta0.97
Next Earnings
May 07, 2024EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.97
Shares Outstanding94,995,823
10 Day Avg. Volume566,460
30 Day Avg. Volume932,176
Standard Deviation0.26
R-Squared0.00020
Alpha0.00169
Financial Highlights & Ratios
Price to Book (P/B)3.09
Price to Sales (P/S)0.54
Price to Cash Flow (P/CF)3.60
P/FCF Ratio0.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.31
Enterprise Value/Gross Profit0.38
Enterprise Value/Ebitda-0.22
Forecast
1Y Price Target
$3.00Price Target Upside245.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Assertio Therapeutics News
PremiumCompany Announcements
Assertio Holdings Chairman Declines Reelection Amid Disputes
PremiumCompany Announcements
Assertio Therapeutics Welcomes Sigurd Kirk to Board
Ownership Overview
20.52% Insiders
11.10% Mutual Funds
10.43% Other Institutional Investors
57.95% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ASRT FAQ
What was Assertio Therapeutics Inc’s price range in the past 12 months?
Assertio Therapeutics Inc lowest stock price was $0.77 and its highest was $8.01 in the past 12 months.
What is Assertio Therapeutics Inc’s market cap?
Currently, no data Available
When is Assertio Therapeutics Inc’s upcoming earnings report date?
Assertio Therapeutics Inc’s upcoming earnings report date is May 07, 2024 which is in 21 days.
How were Assertio Therapeutics Inc’s earnings last quarter?
Assertio Therapeutics Inc released its earnings results on Mar 11, 2024. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0 by $0.11.
Is Assertio Therapeutics Inc overvalued?
According to Wall Street analysts Assertio Therapeutics Inc’s price is currently Undervalued.
Does Assertio Therapeutics Inc pay dividends?
Assertio Therapeutics Inc does not currently pay dividends.
What is Assertio Therapeutics Inc’s EPS estimate?
Assertio Therapeutics Inc’s EPS estimate is -$0.03.
How many shares outstanding does Assertio Therapeutics Inc have?
Assertio Therapeutics Inc has 94,995,830 shares outstanding.
What happened to Assertio Therapeutics Inc’s price movement after its last earnings report?
Assertio Therapeutics Inc reported an EPS of $0.11 in its last earnings report, beating expectations of $0. Following the earnings report the stock price went up 8.602%.
Which hedge fund is a major shareholder of Assertio Therapeutics Inc?
Among the largest hedge funds holding Assertio Therapeutics Inc’s share is Gotham Asset Management LLC. It holds Assertio Therapeutics Inc’s shares valued at 28K.
---
Assertio Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (245.54% Upside)
$3.00 (245.54% Upside)
Blogger Sentiment
Bullish
ASRT Sentiment 88%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 18.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $11.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-85.36%
12-Months-Change
Fundamentals
Return on Equity
-182.52%
Trailing 12-Months
Asset Growth
-30.80%
Trailing 12-Months
Company Description
Assertio Therapeutics Inc
Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.
---
ASRT Stock 12 Months Forecast
Average Price Target
$3.00
▲(245.54% Upside)
Technical Analysis
Best Analysts Covering ASRT
1 Year
1 Year Success Rate
7/30 ratings generated profit
1 Year Average Return
-28.19%
reiterated a buy rating 5 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 23.33% of your transactions generating a profit, with an average return of -28.19% per trade.
---